PLoS Medicine
(Jun 2016)
Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality.
- Kevin Outterson,
- Unni Gopinathan,
- Charles Clift,
- Anthony D So,
- Chantal M Morel,
- John-Arne Røttingen
Affiliations
- Kevin Outterson
- Unni Gopinathan
- Charles Clift
- Anthony D So
- Chantal M Morel
- John-Arne Røttingen
- DOI
-
https://doi.org/10.1371/journal.pmed.1002043
- Journal volume & issue
-
Vol. 13,
no. 6
p.
e1002043
Abstract
Read online
Kevin Outterson and colleagues outline a model to address access, conservation, and innovation of antibiotics.
WeChat QR code